arrow
A

Antonella Cingolani

University of Genoa
H指数:50
被引数:9,294

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study

在意大利,HIV感染者抗逆转录病毒治疗启动时的肥胖与心血管疾病、癌症或死亡的长期风险:一项前瞻性队列研究

2026-08-010
PRE
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT

妊娠期艾滋病病毒诊断延误或漏诊在高收入国家仍然存在,并构成母婴传播的高风险

2026-04-120
OAAI
HIV INFECTION AMONG ADOLESCENTS AND YOUNG ADULTS IN ITALY: EPIDEMIOLOGY, VIRO-IMMUNOLOGICAL AND TREATMENT OUTCOMES

意大利青少年和年轻成人中的HIV感染:流行病学、病毒-免疫学及治疗效果

2025-11-150
OAAI
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments

SARS-CoV-2感染后,活动性血液疾病患者在接受联合抗病毒治疗情况下重新开始抗癌治疗的时间

2025-10-010
OAAI
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort

HIV感染者中一线拉米夫定/多替拉韦抗逆转录病毒疗法的有效性:ICONA基金会队列的真实世界数据

2025-09-010
PRE
HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study

HIV口腔前暴露预防效果、依从性及停药情况在意大利多中心获取计划中的研究:ItaPrEP研究

2025-09-013
OAAI
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years

过去20年意大利接受过抗逆转录病毒治疗的人中HIV晚期疾病的负担

2025-08-120
OAAI
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort

在HIV感染者中,从双重疗法转换为比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺的安全性及有效性:ICONA队列研究的启示

2025-04-280
OAAI
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients

Orchestra Delphi共识:血液病患者SARS-CoV-2感染的诊断和治疗管理

2025-03-210
PRE
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV

ORCHESTRA Delphi共识:人类免疫缺陷病毒感染者中严重急性呼吸综合征冠状病毒2型感染的临床管理

2025-03-210
PRE
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
2024-07-170
OAAI
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
2024-04-063
PRE
Pillars of long-term antiretroviral therapy success

长期抗逆转录病毒疗法成功的支柱

2023-10-013
OAAI
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial

三种不同药物方案治疗原发性HIV-1感染期间hiv-dna减少: 意大利急性HIV感染网络 (无效) 临床试验

2023-09-264
OAAI